Overview
- 5 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-07-15.
At a glance
Inspections
5
Sites
4
Observations
0
Career since
Nov 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Revance Therapeutics, Inc. | 15 Jul 2022 | Human Drugs | On file |
| TERUMO YAMAGUCHI CORPORATION | 21 Feb 2020 | Human Drugs | On file |
| TERUMO YAMAGUCHI CORPORATION | 21 Feb 2020 | Human Drugs | On file |
| PCI San Diego, Inc. | 20 Dec 2019 | Human Drugs | On file |
| Simtra Deutschland GmbH | 5 Nov 2019 | Human Drugs | On file |
Sites inspected
Revance Therapeutics, Inc.Newark, United States1 insp.
TERUMO YAMAGUCHI CORPORATIONYamaguchi, Japan2 insp.
PCI San Diego, Inc.San Diego, United States1 insp.
Simtra Deutschland GmbHHalle (Westf.), Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Wayne E Seifert2 shared
Sarah A Johnson1 shared
Patricia F Hughes Troost1 shared
Zhong Li1 shared
Santiago Gallardo Johnson1 shared
Michael Shanks1 shared
Full investigator report
Get the verbatim findings behind Virginia A Carroll's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site